Healthcare | Global Healthcare Strategist | International Market Expansion Expert | Healthcare Growth Leader
Norway - A frontrunner in #radiopharmaceuticals. Rallybio bought the "innards" (RLYB212) of the #norwegian Biotech Prophylix Pharma in 2019. The company was spun out of the University Hospital in Northern Norway and Oslo University Hospital in 2008 by the inventor Professor Bjorn Skogen, with a Danish CEO engineering the deal - Søren Weis Dahl. Now RallyBio is advancing the asset into #phase2. Innovation Norway | Innovation Norway Americas